ACIU
Price
$2.73
Change
+$0.21 (+8.33%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
253.51M
51 days until earnings call
KALA
Price
$19.26
Change
+$2.36 (+13.96%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
118.66M
Interact to see
Advertisement

ACIU vs KALA

Header iconACIU vs KALA Comparison
Open Charts ACIU vs KALABanner chart's image
AC Immune SA
Price$2.73
Change+$0.21 (+8.33%)
Volume$1.63K
Capitalization253.51M
Kala BIO
Price$19.26
Change+$2.36 (+13.96%)
Volume$1.33K
Capitalization118.66M
ACIU vs KALA Comparison Chart in %
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. KALA commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Buy and KALA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (ACIU: $2.52 vs. KALA: $16.90)
Brand notoriety: ACIU and KALA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 69% vs. KALA: 91%
Market capitalization -- ACIU: $253.51M vs. KALA: $118.66M
ACIU [@Biotechnology] is valued at $253.51M. KALA’s [@Biotechnology] market capitalization is $118.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileKALA’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • KALA’s FA Score: 0 green, 5 red.
According to our system of comparison, ACIU is a better buy in the long-term than KALA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 6 TA indicator(s) are bullish while KALA’s TA Score has 3 bullish TA indicator(s).

  • ACIU’s TA Score: 6 bullish, 5 bearish.
  • KALA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than KALA.

Price Growth

ACIU (@Biotechnology) experienced а -0.79% price change this week, while KALA (@Biotechnology) price change was -7.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.10%, and the average quarterly price growth was +53.89%.

Reported Earning Dates

ACIU is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACIU($254M) has a higher market cap than KALA($119M). KALA YTD gains are higher at: 143.516 vs. ACIU (-6.667). KALA has higher annual earnings (EBITDA): -31.92M vs. ACIU (-48.05M). ACIU has more cash in the bank: 127M vs. KALA (31.9M). ACIU has less debt than KALA: ACIU (4.92M) vs KALA (29.9M). ACIU has higher revenues than KALA: ACIU (28.9M) vs KALA (0).
ACIUKALAACIU / KALA
Capitalization254M119M213%
EBITDA-48.05M-31.92M151%
Gain YTD-6.667143.516-5%
P/E RatioN/AN/A-
Revenue28.9M0-
Total Cash127M31.9M398%
Total Debt4.92M29.9M16%
FUNDAMENTALS RATINGS
ACIU vs KALA: Fundamental Ratings
ACIU
KALA
OUTLOOK RATING
1..100
1810
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4634
P/E GROWTH RATING
1..100
8397
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (48) in the Pharmaceuticals Major industry is in the same range as KALA (62). This means that ACIU’s stock grew similarly to KALA’s over the last 12 months.

ACIU's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as KALA (100). This means that ACIU’s stock grew similarly to KALA’s over the last 12 months.

ACIU's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as KALA (100). This means that ACIU’s stock grew similarly to KALA’s over the last 12 months.

KALA's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as ACIU (46). This means that KALA’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's P/E Growth Rating (83) in the Pharmaceuticals Major industry is in the same range as KALA (97). This means that ACIU’s stock grew similarly to KALA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUKALA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 27 days ago
87%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLNS1.05N/A
N/A
Golden Star Resource Corp
NDBKF13.50N/A
N/A
Nedbank Group, Ltd.
AURX1.80N/A
-0.14%
Nuo Therapeutics, Inc.
CFPZF9.37-0.02
-0.21%
Canfor Corp.
FSUMF12.80-0.05
-0.43%
FORTESCUE LTD.

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with RGNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
-0.40%
RGNX - ACIU
40%
Loosely correlated
-1.43%
IRON - ACIU
39%
Loosely correlated
+1.08%
IMVT - ACIU
39%
Loosely correlated
-4.43%
ARCT - ACIU
36%
Loosely correlated
-3.66%
LRMR - ACIU
36%
Loosely correlated
-0.89%
More

KALA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALA has been loosely correlated with ABCZF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KALA jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
-8.89%
ABCZF - KALA
42%
Loosely correlated
N/A
VICP - KALA
29%
Poorly correlated
N/A
ACIU - KALA
29%
Poorly correlated
-0.40%
SYRE - KALA
28%
Poorly correlated
+4.77%
VTGN - KALA
28%
Poorly correlated
+3.30%
More